Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Bell

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Science (New York, N.Y.)|July 24, 1981
Calcitonin messenger RNA encodes multiple polypeptides in a single precursorJ W Jacobs, R H Goodman, W W Chin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Collagen N-telopeptide excretion in men: the effects of age and intrasubject variabilityE S Orwoll, N H Bell, M S Nanes, et al.
The New England Journal of Medicine|May 4, 1978
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin DM H Brooks, N H Bell, L Love, et al.
The Journal of Clinical Investigation|March 1, 1982
Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in manP W Lambert, P H Stern, R C Avioli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1990
Alteration of vitamin D metabolism in Mexican-AmericansC A Reasner, J F Dunn, D A Fetchick, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 12, 2000
Clinical use of biochemical markers of bone remodeling: current status and future directionsA C Looker, D C Bauer, C H Chesnut, et al.
The New England Journal of Medicine|November 30, 1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study GroupU A Liberman, S R Weiss, J Bröll, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal womenR W Downs, N H Bell, M P Ettinger, et al.
The American Journal of Medicine|August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelingC H Chesnut, M R McClung, K E Ensrud, et al.
The American Journal of Medicine|January 1, 1997
Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral densityC H Chesnut, N H Bell, G S Clark, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Science (New York, N.Y.)|July 24, 1981
Calcitonin messenger RNA encodes multiple polypeptides in a single precursorJ W Jacobs, R H Goodman, W W Chin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Collagen N-telopeptide excretion in men: the effects of age and intrasubject variabilityE S Orwoll, N H Bell, M S Nanes, et al.
The New England Journal of Medicine|May 4, 1978
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin DM H Brooks, N H Bell, L Love, et al.
The Journal of Clinical Investigation|March 1, 1982
Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in manP W Lambert, P H Stern, R C Avioli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1990
Alteration of vitamin D metabolism in Mexican-AmericansC A Reasner, J F Dunn, D A Fetchick, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 12, 2000
Clinical use of biochemical markers of bone remodeling: current status and future directionsA C Looker, D C Bauer, C H Chesnut, et al.
The New England Journal of Medicine|November 30, 1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study GroupU A Liberman, S R Weiss, J Bröll, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal womenR W Downs, N H Bell, M P Ettinger, et al.
The American Journal of Medicine|August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelingC H Chesnut, M R McClung, K E Ensrud, et al.
The American Journal of Medicine|January 1, 1997
Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral densityC H Chesnut, N H Bell, G S Clark, et al.
Pageof 15